Completed
Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers
NCT02293148
- Conditions
- Anaemia, Anemia, Hematologic Diseases, +1 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States